[AsCNP_P4] Poster Session 4
Bipolar Disorders 1

[AsCNP-P4-1] Efficacy of Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled 6-week Study (ELEVATE study)

^○Takahiro MASUDA¹, Tadafumi KATO², Jun ISHIGOOKA³, Kei WATABE¹, Mari MIYAJIMA¹, Teruhiko HIGUCHI^{4, 5} (1. Sumitomo Dainippon Pharma Co., Ltd., Japan, 2. RIKEN Brain Science Institute, Japan, 3. Institute of CNS Pharmacology, Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)